UNSPSC 51241530: Naphazoline/pheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP900. This VA Drug Class (OP900) classifies this compound as belonging to the group OPHTHALMICS, OTHER.

UNSPSC 51241530 Naphazoline/pheniramine, a Commodity code, describes ophthalmic and nasal decongestant medications that state and local governments procure through cooperative purchasing agreements and multistate consortia to supply health clinics, correctional facilities, emergency departments, and other public health operations. The scope covers generic and over-the-counter formulations supplied via authorized pharmaceutical wholesalers under master agreements that establish NDC-level pricing, administrative fee structures, and supply-chain compliance obligations.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal in January 2026 to establish multiple manufacturer contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. MMCAP serves participating state and local government facilities across Minnesota and Oregon. The RFP requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and mandates current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance. Vendors must maintain contractual relationships with at least two of the three wholesalers, carry commercial general liability insurance of $5,000,000 per occurrence, and agree to a 3 percent administrative fee on all contract purchases. The contract term runs two years for new vendors with optional extensions through June 30, 2028, and evaluation weights price competitiveness at 75 percent, with the remaining 25 percent split across fixed pricing (10 percent), administrative data format compliance (5 percent), EDI capability (5 percent), and fee agreement (5 percent).